Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 517.95
(1.61%)
INR 517.95
(1.61%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -145.27 INR | -2258.28% |
| 2022 | -6.16 INR | 61.93% |
| 2021 | -16.18 INR | -123.45% |
| 2020 | 69.00 INR | 55.79% |
| 2019 | 44.29 INR | 83.7% |
| 2018 | 24.11 INR | 15973.33% |
| 2017 | 0.15 INR | -99.44% |
| 2016 | 26.94 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -3.50 INR | 94.65% |
| 2024 Q2 | 2.54 INR | 147.71% |
| 2023 Q4 | -65.37 INR | 14.54% |
| 2023 FY | - INR | -2258.28% |
| 2023 Q1 | -5.43 INR | -617.14% |
| 2023 Q2 | -4.77 INR | 12.15% |
| 2023 Q3 | -76.49 INR | -1503.56% |
| 2022 Q2 | -2.77 INR | 39.39% |
| 2022 Q4 | 1.05 INR | 707.69% |
| 2022 FY | - INR | 61.93% |
| 2022 Q1 | -4.57 INR | -962.26% |
| 2022 Q3 | 0.13 INR | 104.69% |
| 2021 Q2 | 8.27 INR | -40.72% |
| 2021 FY | - INR | -123.45% |
| 2021 Q1 | 13.95 INR | -12.26% |
| 2021 Q4 | 0.53 INR | 101.36% |
| 2021 Q3 | -38.93 INR | -570.74% |
| 2020 Q1 | 15.75 INR | 160.76% |
| 2020 Q4 | 15.90 INR | -13.91% |
| 2020 FY | - INR | 55.79% |
| 2020 Q2 | 19.21 INR | 21.97% |
| 2020 Q3 | 18.47 INR | -3.85% |
| 2019 Q4 | 6.04 INR | -62.25% |
| 2019 Q3 | 16.00 INR | 42.73% |
| 2019 Q2 | 11.21 INR | 8.94% |
| 2019 FY | - INR | 83.7% |
| 2019 Q1 | 10.29 INR | 15.36% |
| 2018 FY | - INR | 15973.33% |
| 2018 Q4 | 8.92 INR | -0.45% |
| 2018 Q3 | 8.96 INR | 158.96% |
| 2018 Q2 | 3.46 INR | 1404.35% |
| 2018 Q1 | 0.23 INR | -90.98% |
| 2017 Q2 | 6.85 INR | -51.52% |
| 2017 Q1 | 14.13 INR | 0.0% |
| 2017 FY | - INR | -99.44% |
| 2017 Q4 | 2.55 INR | 0.0% |
| 2016 FY | - INR | 0.0% |